Camurus receives Canadian approval for Oczyesa XR for acromegaly
Akeso reports first patient dosed in Phase III study of cadonilimab in colon cancer
Glaukos reports positive Phase 4 results for iDose TR with cataract surgery
Medincell partner Teva secures FDA approval for monthly schizophrenia treatment
Alumis reports new Phase 3 data showing sustained skin clearance with envudeucitinib
FDA approves Genentech's Tecentriq combination therapy for stage III colon cancer
Sophos IRB and ALCMI partner to support lung cancer research
Innovent Biologics achieves primary study endpoint for inactive thyroid eye disease antibody
argenx reports positive Phase 2 results for FB102 in coeliac disease
Vir Biotechnology's VIR-5500 receives FDA Fast Track designation for prostate cancer
FDA accepts Bayer's application for KERENDIA in chronic kidney disease without diabetes
WuXi AppTec awarded EcoVadis gold medal for third year
Suzhou Ribo Life Science submits Phase I Clinical Trial Application for RBD3133 in EU